[
  {
    "vignette_index": 1153,
    "input": "Ischemic Stroke END",
    "output": "THINKING: Use systematic clinical reasoning to develop your treatment approach:  STEP 1 - DIAGNOSIS CONFIRMATION & SEVERITY ASSESSMENT: Let me first confirm the diagnosis and assess severity/urgency. - Primary diagnosis confidence: The initial diagnosis is ischemic stroke, but the patient's final diagnosis is dissociative neurological symptom disorder with paresis or weakness, suggesting a functional (psychogenic) origin rather than an actual stroke. - Severity classification: The symptoms are described as significant and worsening, but since neuroimaging is pending, the clinical severity is presumed moderate until confirmed. - Urgency level: Urgent care is required today for thorough evaluation to exclude organic causes like stroke. - Differential considerations still requiring monitoring: Organic stroke or demyelinating disease; psychiatric dissociative disorder remains primary due to clinical presentation.  STEP 2 - EVIDENCE-BASED TREATMENT SELECTION: Now I'll select treatments based on current clinical guidelines. - First-line treatment per guidelines: For dissociative neurological symptom disorder, reassurance, patient education, and psychotherapy are first-line. - Supporting evidence: Evidence suggests that psychological therapy, particularly cognitive-behavioral therapy, can improve functional neurological symptoms. - Patient-specific considerations: The patient's anxiety and fluctuating symptoms suggest a psychogenic component; reassurance is key. - Contraindications or cautions: Avoid unnecessary invasive procedures; ensure organic causes are ruled out.  STEP 3 - PHARMACOLOGICAL INTERVENTIONS: If medications are needed, mainly to address anxiety or comorbidities. - Primary medication choice: Consider an SSRI such as sertraline 25-50 mg daily if anxiety or depressive symptoms are prominent. - Rationale for selection: SSRIs are effective for anxiety and depression, which may exacerbate symptom perception. - Expected timeline for improvement: 4-6 weeks. - Key side effects to monitor: Gastrointestinal symptoms, sleep disturbances, increased anxiety initially. - Alternative medications if first-line fails: Other SSRIs, SNRIs, or low-dose benzodiazepines for short-term use if severe anxiety.  STEP 4 - NON-PHARMACOLOGICAL INTERVENTIONS: I'll include lifestyle and behavioral interventions. - Primary non-drug interventions: Initiate supportive psychotherapy, focus on reassurance, and education about the functional nature of symptoms. - Patient education priorities: Clarify that symptoms are real but not due to organic neurological damage; stress the importance of ongoing evaluation. - Lifestyle modifications: Encourage stress management techniques, regular sleep, and mild physical activity as tolerated. - Behavioral interventions: Cognitive-behavioral therapy or referral to a mental health specialist.  STEP 5 - MONITORING & FOLLOW-UP STRATEGY: I'll establish care plan. - Follow-up timeline: Reassess in 1-2 weeks or sooner if worsening. - Monitoring parameters: Symptom progression, patient-reported distress, mental health status. - Red flag symptoms: Sudden worsening, new neurological deficits, or signs of underlying organic neurological illness. - Treatment response assessment: Improvement in symptom consistency, reduced distress, and functional status.  STEP 6 - PATIENT COMMUNICATION STRATEGY: Given her baseline behavioral type, I will communicate empathetically. - Communication approach: Use clear, reassuring language emphasizing that symptoms are real but treatable and often linked to psychological stress. - Addressing patient concerns: Acknowledge her distress, validate her experience, and explain the rationale for psychological therapy. - Adherence strategies: Set achievable goals, involve her in care planning, and schedule regular follow-ups. - Family involvement: Encourage family support and education to foster understanding.  STEP 7 - COORDINATION & REFERRALS: Additional care coordination. - Specialist referrals needed: Neuropsychiatry or psychology services for therapy. - Other healthcare team members: Primary care provider, mental health professionals. - Community resources: Support groups for functional neurological symptoms. - Insurance/cost considerations: Verify coverage for mental health services, provide resources accordingly.\nANSWER: Based on the diagnosis of dissociative neurological symptom disorder with paresis or weakness, I recommend a comprehensive treatment approach that combines evidence-based psychological management with patient-centered care strategies. The treatment plan includes initiating supportive psychotherapy focused on symptom education, reassurance, and stress management, with consideration for pharmacotherapy such as SSRIs if anxiety is significant. Immediate actions involve ruling out organic causes through neuroimaging and neurological assessment. Short-term goals include symptom stabilization and patient education within 1-2 weeks, while long-term management focuses on ongoing psychotherapy, stress reduction, and monitoring for symptom improvement over 3-6 months. Follow-up will be scheduled regularly to assess progress, address concerns, and adjust therapy as needed. This approach aims to improve her functional status, reduce distress, and prevent unnecessary interventions, all while respecting her baseline behavioral style and ensuring coordinated mental health support.",
    "gold_diagnosis": "Dissociative neurological symptom disorder, with paresis or weakness"
  }
]